Skip to content

Real-world study on the prevention effect of Lian-Hua Qing-Wen Capsules on close contacts of new coronavirus pneumonia

Real-world study on the prevention effect of Lian-Hua Qing-Wen Capsules on close contacts of new coronavirus pneumonia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004374
Enrollment
Unknown
Registered
2021-02-04
Start date
2021-02-04
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Confirmed as a close contact with the novel coronavirus pneumonia through flow investigation; 2. Over 12 years old (including 12 years old), no gender limit; 3. Voluntarily sign a written informed consent before the start of the study.

Exclusion criteria

Exclusion criteria: 1. Confirmed as a confirmed case of new coronavirus pneumonia after pathogenic testing and clinical manifestations or signs; 2. Allergies, such as those with a history of allergies to two or more drugs or foods, or those who are known to be allergic to the ingredients of this drug; 3. Women who are pregnant or breastfeeding; 4. The researcher considers it inappropriate to participate in this research.

Design outcomes

Primary

MeasureTime frame
Nucleic acid test positive rate of nasal and throat swabs during the isolation medical observation period;

Secondary

MeasureTime frame
Proportion of mild, normal, and severe patients with positive nucleic acid tests;Time of occurrence of positive nucleic acid tests in nasal and throat swabs during the isolation medical observation period;Proportion of asymptomatic infections among positive nucleic acid tests;Date of onset during the isolation medical observation period (that is, the time when the clinical symptoms of the case appeared);Grading of the severity of symptoms during medical observation;

Countries

China

Contacts

Public ContactGao Fu/Liu Qingquan/Yuan Yadong

The Second Hospital of Hebei Medical University

yydzzy62@sina.com+86 15803210960

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026